Pyxis Oncology, Inc.PYXSNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
3.94%
↓ 93% below average
Average (22q)
55.89%
Historical baseline
Range
High:944.09%
Low:-90.22%
Volatility
1850.5%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 3.94% |
| Q2 2025 | 0.52% |
| Q1 2025 | 21.53% |
| Q4 2024 | -20.95% |
| Q3 2024 | 27.15% |
| Q2 2024 | 7.09% |
| Q1 2024 | 12.25% |
| Q4 2023 | -20.97% |
| Q3 2023 | 28.94% |
| Q2 2023 | -4.29% |
| Q1 2023 | -60.14% |
| Q4 2022 | 56.85% |
| Q3 2022 | 10.86% |
| Q2 2022 | -14.45% |
| Q1 2022 | 177.76% |
| Q4 2021 | -7.94% |
| Q3 2021 | 144.90% |
| Q2 2021 | -90.22% |
| Q1 2021 | 944.09% |
| Q4 2020 | 29.44% |
| Q3 2020 | 39.21% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |